Provided by Tiger Trade Technology Pte. Ltd.

Bruker

38.07
+1.564.27%
Volume:2.12M
Turnover:79.99M
Market Cap:5.78B
PE:-253.80
High:38.20
Open:36.78
Low:36.54
Close:36.51
52wk High:56.22
52wk Low:28.53
Shares:151.94M
Float Shares:103.15M
Volume Ratio:0.64
T/O Rate:2.06%
Dividend:0.20
Dividend Rate:0.53%
EPS(TTM):-0.1500
EPS(LYR):-0.1500
ROE:-0.38%
ROA:2.44%
PB:2.34
PE(LYR):-253.80

Loading ...

Company Profile

Company Name:
Bruker
Exchange:
NASDAQ
Establishment Date:
1960
Employees:
11396
Office Location:
40 Manning Road,Billerica,Massachusetts,United States
Zip Code:
01821
Fax:
978 663 5585
Introduction:
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Directors

Name
Position
Frank H. Laukien
Chairman, President and Chief Executive Officer
Adelene Q. Perkins
Director
Bonnie H. Anderson
Director
Cynthia M. Friend
Director
Hermann Requardt
Director
Jack J. Phillips
Director
John Ornell
Director
Laura A. Francis
Director
Richard A. Packer
Director
Robert Rosenthal
Director
William A. Linton
Director

Shareholders

Name
Position
Burkhard Prause
President and Chief Executive Officer, Bruker Energy & Supercon Technologies, Inc.
Frank H. Laukien
Chairman, President and Chief Executive Officer
Gerald N. Herman
Executive Vice President and Chief Financial Officer
Falko Busse
President, Bruker BioSpin Group
Juergen Srega
President, Bruker CALID Group and Bruker Daltonics Division
Mark R. Munch
Executive Vice President, President of Bruker NANO Group and Bruker NANO Surfaces Division